DEXA

DEXA Dilemmas: Clarifying Recommendations for Osteoporosis Screening

By Caila Brander | Jan 30, 2018 | Comments Off on DEXA Dilemmas: Clarifying Recommendations for Osteoporosis Screening

With so much industry-sponsored content, who can you trust to figure out the truth about osteoporosis? Is it a serious threat to women’s health? Should you be getting bone scans, or considering medication?

When Should I Start Getting Bone Scans for Osteoporosis?

By Evita Almassi | Nov 9, 2017 | Comments Off on When Should I Start Getting Bone Scans for Osteoporosis?

Age is not the only factor that influences our bones. However, women who are around or past the menopausal age are more prone to bone weakening, increasing the risks of osteoporosis.

Osteoporosis: Innovations in Screening and Diagnostics

By NWHN Staff | Nov 2, 2017 | Comments Off on Osteoporosis: Innovations in Screening and Diagnostics

Once a procedure becomes routine, it is difficult to replace. However, the NWHN is committed to a vision of osteoporosis care where all women who need it can receive effective screening in order to prevent unnecessary fractures through both medication and non-pharmacologic interventions.

Are “Scary Bone Drugs” Necessary to Prevent Fractures?

By NWHN Staff | Jul 13, 2016 | Comments Off on Are “Scary Bone Drugs” Necessary to Prevent Fractures?

The NWHN acknowledges the overbearing influence pharmaceutical companies have on doctors and patients. This issue arises for those diagnosed with high bone fracture risk. Women are specifically targeted since they’re five times more likely to be diagnosed than men.

Osteoporosis: Better Screening, Treatment Policy Issues

By NWHN Staff | Aug 14, 2015 | Comments Off on Osteoporosis: Better Screening, Treatment Policy Issues

The way we screen and treat osteoporosis is still deeply flawed. The NWHN thinks women deserve better, and we’re fighting to make that vision a reality.

Osteoporosis: Screening and Diagnosis

By NWHN Staff | Jul 9, 2015 | Comments Off on Osteoporosis: Screening and Diagnosis

Pharmaceutical companies trying to sell drugs have pushed for the adoption of flawed screening techniques that medicalized age-related bone loss. The result? Many healthy women were prescribed osteoporosis drugs despite their serious side effects and risks.

Rx for Change: Choosing Wisely on Getting a Bone Density Test

By Charlea T. Massion, MD, and Adriane Fugh-Berman, MD | Jul 1, 2014 | Comments Off on Rx for Change: Choosing Wisely on Getting a Bone Density Test

Recommendations about bone density (BD) testing have shifted over the last few years — we are proud to say, more toward what the NWHN has recommended for over a decade! This article reviews the BD testing recommendations from the Choosing Wisely® campaign.